COVID-19

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read More

Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read More

As students returned to campus amid numerous COVID-19 safety protocols, they found new ways to connect. Here, students enjoy a physically distant lunch together in front of the newly opened Nicholas S. Zeppos College. Read More

As we continue to navigate a fall semester like no other, and as I embark on my first academic year as Vanderbilt’s chancellor, I am increasingly impressed by the strength of our university community. Read More

It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection. Read More

AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. Read More

Lisa Fazio, assistant professor of psychology and human development at Peabody College, shares a few tips on how to avoid knowledge neglect and spreading misinformation. Read More

Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development. Read More

New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment. Read More

Physician-scientists at Vanderbilt University Medical Center are investigating whether SARS-CoV-2, the virus that causes COVID-19, can be spread through aerosolized emissions (microscopic droplets and particles) during minimally invasive surgery in children. Read More

Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19. Read More

As the new academic year approaches, Vanderbilt's faculty heads of house are revealing some things about themselves in this special portrait series. Meet Celso Thomas Castilho, associate professor of history and faculty head of Memorial House. Read More

The U.S. Navy’s Blue Angels flight demonstration squadron soar directly above Vanderbilt Stadium on May 14 during a series of nationwide flyovers, which included Nashville. Read More

As the new academic year approaches, Vanderbilt’s faculty heads of house are revealing some things about themselves in this special portrait series. Get to know Christoph Zeller, associate professor of German studies and of European studies and faculty head of West House. Read More

Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19. Read More

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial. Read More

This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported that remdesivir potently inhibited SARS-CoV-2, the virus which causes COVID-19, in human lung cell cultures and that it improved lung function in mice infected with the virus. Read More

What will traffic look like if transit riders become car drivers? A new article, published online by the Work Research Group at Vanderbilt, takes a hard look at transportation modes during and after the COVID-19 pandemic. Read More

The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19. Read More

Vanderbilt's Data Science Institute researchers are developing a model to use big data to address the impact of COVID-19 on policies, procedures, and resources now and in the future. The tool will help Monroe Carell Jr. Children's Hospital at Vanderbilt evaluate short- and long-term resource needs in order to be fully prepared to meet patients' needs. Read More